BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17058913)

  • 1. [Neurofibromatosis type 2].
    Gong S; Chen G; Zhong G; Yan K; Zhang E; Chen P; Lin N; Nie X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Aug; 20(16):721-3. PubMed ID: 17058913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of auditory and vestibular function after surgical removal of bilateral vestibular schwannomas in a patient with neurofibromatosis type 2.
    Black FO; Brackmann DE; Hitselberger WE; Purdy J
    Am J Otol; 1995 Jul; 16(4):431-43. PubMed ID: 8588642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
    Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y
    Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
    Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis 2: two case reports.
    Drsata J; Celakovský P; Vokurka J; Lánský M
    Int Tinnitus J; 2003; 9(2):116-8. PubMed ID: 15106286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 2. Case report.
    Kuchna I; Zabek M; Dambska M; Matyja E; Wierzba-Bobrowicz T
    Folia Neuropathol; 1995; 33(3):141-4. PubMed ID: 8705281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing preservation in neurofibromatosis type 2.
    Slattery WH; Brackmann DE; Hitselberger W
    Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management strategies in neurofibromatosis type 2.
    Moffat DA; Quaranta N; Baguley DM; Hardy DG; Chang P
    Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):12-8. PubMed ID: 12520350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurofibromatosis type 2].
    Pérez-Grau M; Miró N; Prades J; Vergés J; Lareo S; Roca-Ribas F
    Acta Otorrinolaringol Esp; 2010; 61(4):306-11. PubMed ID: 20138250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurofibromatosis type 2 in the otorhinolaryngological practice].
    Subbotina MV; Berseneva AV
    Vestn Otorinolaringol; 2024; 89(1):37-41. PubMed ID: 38506024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.
    Tibussek D; Hübsch S; Berger K; Schaper J; Rosenbaum T; Mayatepek E
    Klin Padiatr; 2009; 221(4):247-50. PubMed ID: 19629903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hearing in pediatric NF2.
    Shepard TH; Tucci DL; Grant GA; Kaylie DM
    Otol Neurotol; 2012 Aug; 33(6):1066-70. PubMed ID: 22710553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 2 initially presenting as a preauricular mass: a case report.
    Lan WC; Aoh Y; Chen RY; Tien HC; Lin CD
    J Otolaryngol Head Neck Surg; 2020 Jun; 49(1):45. PubMed ID: 32591014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management strategy of vestibular schwannoma in neurofibromatosis type 2.
    Odat HA; Piccirillo E; Sequino G; Taibah A; Sanna M
    Otol Neurotol; 2011 Sep; 32(7):1163-70. PubMed ID: 21817944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuroimaging and clinical spectrum of neurofibromatosis 2.
    Mautner VF; Lindenau M; Baser ME; Hazim W; Tatagiba M; Haase W; Samii M; Wais R; Pulst SM
    Neurosurgery; 1996 May; 38(5):880-5; discussion 885-6. PubMed ID: 8727812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.